Ciro Isidoro is a full Professor of General Pathology at the Department of Health Sciences, University of Piemonte Orientale (Novara, Italy). He holds a Doctor of Science degree in Biological Sciences (Magna Cum Laude) and a Doctor of Medicine and Surgery degree (Magna Cum Laude). He has been a PhD fellow and Assistant Researcher at the Institut für Pathobiochemie, Westfälische Wilhelms-Universität Münster in Germany. Professor Isidoro has been awarded Professor Honoris Causa by the Faculty of Medicine and Pharmacy at the Université de la Franche-Comté in Besançon, France. He is a visiting professor at the Siriraj Faculty of Medicine, Mahidol University in Bangkok, Thailand, and at the Department of Cell Biology, Oklahoma University Health Science Center in Oklahoma City, USA. Professor Isidoro is the Editor-in-Chief of the Journal of Traditional and Complementary Medicine and of the Journal of Cancer and Metastasis Treatment, and Associate Editor of Autophagy, Molecular Carcinogenesis, Cancers, Frontiers in Oncology, Cells, Biomedicines, and the International Journal of Molecular Sciences, among others. Professor Isidoro is a globally recognized expert in autophagy and lysosome biogenesis. His research primarily focuses on the role of autophagy-lysosomal degradation in cancer, neurodegenerative diseases, and the epigenetic mechanisms of anti-tumor nutraceuticals. Professor Isidoro has been listed as a TOP 2% scientist in the world in 2023 and a TOP Italian scientist.